Abstract-In atheroma, T cell-derived interferon-␥ (INF-␥) stimulates endothelial cells and facilitates recruitment of monocytes. We investigated potential mechanisms by which these interactions could contribute to local and systemic inflammatory responses. Specifically, we analyzed the expression of interleukin (IL)-1␤ and IL-6 in both cell types after coculture, the relevant adhesion molecules in this interaction, and transcriptional control by NF-B. We studied coculture of purified peripheral blood monocytes with human umbilical vein endothelial cells ( 
A therosclerosis is an inflammatory disease with both local vascular and systemic components. [1] [2] [3] [4] [5] Systemic inflammatory responses in atherosclerosis carry an increased risk of ischemic complications, as indicated by several lines of evidence. The plasma level of C-reactive protein, the central inflammatory marker protein, is an independent predictor of the risk of major cardiac events in patients with unstable angina as well as in apparently healthy men. 4 -7 Likewise, leukocyte counts are important determinants of the risk of acute myocardial infarction and its recurrence. 8 Moreover, fibrinogen, which is upregulated in inflammation, is an established cardiovascular risk factor. 9, 10 Clarification of the underlying mechanisms for systemic inflammatory responses may thus have important therapeutic implications.
Most of the systemic inflammatory responses in atherosclerosis can be explained by an action of interleukin (IL)-6. IL-6 is the main inducer of the hepatic synthesis of C-reactive protein, fibrinogen, and other acute-phase proteins and cooperates with various hemopoietic cytokines in elevating leukocyte and platelet counts. [11] [12] [13] [14] Several studies found increased concentrations of IL-6 in the peripheral blood of patients with advanced stages of atherosclerotic disease. [15] [16] [17] IL-6 has also been recovered from atheroma. 3 It is therefore generally believed that the systemic inflammatory responses in atherosclerosis are largely regulated by IL-6 released from plaques.
According to the response-to-injury hypothesis, ␤ 1 -and ␤ 2 -integrin-mediated recruitment of monocytes and T cells to the subendothelial space sets the stage for a variety of inflammatory interactions between blood cells and vascular cells. 2,18 -20 Analysis of the cytokine contents of atherosclerotic lesions suggests IL-1, tumor necrosis factor-␣, and interferon (INF)-␥ as the key mediators in this setting. 1 The mechanisms for expression and release of IL-6 in atheroma, however, are still incompletely understood. Recently, Lukacs et al 21 showed that adhesion of monocytes to INF-␥-stimu-lated endothelial cells induced expression of chemokines, such as monocyte chemoattractant protein-1 (MCP-1) and IL-8. We speculated that adhesion of monocytes to INF-␥-stimulated endothelial cells could also induce expression of IL-6. Such interactions could play an important role in atheroma, because activated T lymphocytes within the lesion secrete large amounts of INF-␥. 2, 3 To gain further insight into potential mechanisms that regulate IL-6 in atherosclerosis, we studied the interaction of monocytes with INF-␥-stimulated endothelial cells. Specifically, we investigated the expression of IL-1␤ and IL-6 in both cell types after coculture, the role of selectin-or integrin-supported adhesion in this interaction, and transcriptional control by nuclear factor (NF)-B.
Methods

Cell Isolation
Peripheral blood was drawn from healthy volunteers, and the mononuclear cell fraction was prepared by Ficoll-Hypaque gradient technique (Pharmacia). 22 Neutrophil contamination was consistently Ͻ5%. To obtain purified peripheral blood monocytes, we performed an additional gradient centrifugation with Percoll (Pharmacia). The purity of monocytes was Ͼ85%, with Ͼ95% viable cells (trypan blue exclusion). 23 
Endothelial Cells
Primary human umbilical vein endothelial cells (HUVECs) were harvested by collagenase (Worthington) digestion as described. 24 Cells were grown in 6-well culture plates (NUNC) in endothelial cell growth medium (modified MCBD 131 media, Boehringer Ingelheim) and were used as confluent monolayers after 1 to 2 passages. ECV-304, an immortal human endothelial cell line (American Type Culture Collection, ATCC), was cultured in complete medium 199 (Sigma) containing 10% FCS, 2 mmol/L glutamine, 100 U/L penicillin, and 100 mg/L streptomycin.
To obtain preactivated endothelial cells, we incubated confluent monolayers for 16 hours with human recombinant INF-␥ at a concentration of 10 6 U/L (Pepro Tech). Thereafter, INF-␥ was removed by 3 gentle washes with 1 mL prewarmed culture medium. The wash medium was carefully and completely removed after each wash. INF-␥ increased the surface expression of intercellular adhesion molecule (ICAM)-1 by 273Ϯ15% on HUVECs and by 331Ϯ75% on ECV-304, whereas endothelial surface expression of E-selectin or vascular cell adhesion molecule (VCAM)-1 was not altered significantly.
Coculture of Monocytes and HUVECs
Coculture experiments were performed in culture medium in the presence of 1 mmol/L CaCl 2 and 10 g/L polymyxine (Sigma) with or without IL-1-receptor antagonist (RA) at 100 g/L. We added 1 mL of suspension of washed mononuclear cells or purified monocytes containing 5ϫ10 6 or 1ϫ10 6 cells, respectively, to confluent monolayers of nonstimulated or INF-␥-stimulated endothelial cells grown on 6-well plates. Cocultures in transwell chambers (Costar, pore size 0.4 m) served as controls. Culture supernatants were collected at the times indicated and assayed for IL-1␤ and IL-6 by ELISA (Biermann) with detection limits of 3.9 ng/L for IL-1␤ and 30 ng/L for IL-6.
In some experiments, endothelial cells had been preincubated for 1 hour with blocking anti-ICAM-1 monoclonal antibodies (mAbs) (clone 84H10: reacts with extracellular part and blocks adhesion; Immunotech), blocking anti-VCAM-1 mAbs (clone BBJG-V1, blocks adhesion, R&D Systems, and clone 1G11, blocks adhesion, Immunotech) at 5 mg/L, blocking anti-E-selectin mAbs (clone 1.2B6, blocks adhesion, Immunotech), anti-L-selectin mAbs (clone Dreg 56, blocks L-selectin-mediated binding, Immunotech) at 5 mg/L, or anti-P-selectin mAbs (G1, blocks P-selectin-mediated adhesion, Centocor) at 10 mg/L. In other experiments, purified monocytes had been preincubated with blocking anti-␣ 4 -integrin mAbs (clone 2B4, blocks very late antigen [VLA]-4 -dependent adhesion of monocytes to VCAM-1, R&D Systems), anti-␤ 1 -integrin mAbs (clone Lia1/2, blocks adhesion, Immunotech), or anti-CD 11b mAbs (clone 44; recognizes the ␣M-chain of Mac-1 and blocks adhesion, Cymbus Biotechnology) at 5 mg/L.
To eliminate endotoxin contamination, all crystalloid solutions were ultrafiltered (U2000, Gambro), and stock solutions of proteins were decontaminated by polymyxin columns (Pierce). In addition, we assayed potential endotoxin contamination of all cell suspensions at the end of each experiment by chromogenic limulus amoebocyte lysate assay (Schulz).
Flow Cytometry
Immunofluorescence staining and flow cytometry were performed as described previously. 15 In brief, HUVECs were harvested and resuspended in fresh medium, and 40 L of cell suspension was incubated with saturating concentrations of FITC-conjugated anti-VCAM-1 mAbs (Immunotech), FITC-conjugated anti-ICAM-1 mAbs (Immunotech), or FITC-conjugated anti-E-selectin mAbs (Immunotech) for 30 minutes at 4°C. Cell suspension was washed 3 times and stored in 1% paraformaldehyde at 4°C until flow cytometry analysis was performed within 12 hours.
RNA Preparation, Northern Blot Analysis, and Electrophoretic Mobility Shift Assay
After coculture of ECV-304 and mononuclear cells for the times indicated, mRNA and nuclear extracts were analyzed in each cell type separately. To harvest the adherent mononuclear cells, we washed the wells twice with ice-cold 0.02% EDTA/PBS, pH 7.4, for 3 minutes. ECV-304 contamination in this cell fraction was Ͻ1%. Monocyte contamination in the endothelial fraction was also negligible, as shown by light microscopy. Likewise, we were unable to detect mRNA expression of the monocyte-specific ␤ 2 -integrin chain in the endothelial cell fraction, whereas a strong signal was found in the monocyte fraction.
As a positive control for Northern blot analysis, mononuclear cells were stimulated with lipopolysaccharide (0.1 mg/L) for 2 hours. Total RNA of 10 7 ECV-304 cells or 2.5ϫ10 7 mononuclear cells was isolated with the RNeasy Mini Kit (Qiagen GmbH) and analyzed by Northern blotting as described previously. 25 Briefly, 5 g of total RNA of each sample was subjected to electrophoresis on a 1.2% agarose gel containing 100 mmol/L MOPS (Boehringer), 40 mmol/L sodium acetate (Boehringer), 5 mmol/L EDTA, and 6% formaldehyde (Boehringer). The RNA was transferred to nylon membrane (Hybond-N, Amersham) in 20ϫ SSC (Merck) by capillary blotting overnight. Blots were baked and prehybridized at 42°C in 50% formamide (Merck), 5ϫ Denhardt's solution, 5ϫ SSC, 0.5% SDS (Merck), and 20 mmol/L salmon sperm DNA (Gibco BRL). Blots were probed with the 1.06-kb PstI fragment of IL-1␤ pBR322 (ATCC), the 1.0-kb EcoR1 fragment of IL-6 p91023(B) (ATCC), and the 0.6-kb EcoR1 fragment of ␤ 2 -integrin pGemTeasy (kindly provided by P. Baeuerle, Micromet) to assess contamination of the endothelial cell fraction with adherent or transmigrated monocytes and reprobed with the 1.3-kb PstI-Xba fragment of pUC19-GAPDH to ensure integrity of total RNA and comparable RNA loading in each lane.
The cDNA probes were radiolabeled by random priming with [␣-P 32 ]dCTP (Ͼ6000 Ci/mmol) (Amersham). The blots were washed at 60°C in 1% SDS/2ϫ SSC and autoradiographed with Kodak X-omat film at Ϫ70°C with an intensifying screen.
Nuclear extracts from 10ϫ10 6 ECV-304 cells and 10ϫ10 7 mononuclear cells per sample were prepared and analyzed for NF-B and SP-1 binding as described previously. 26, 27 The B consensus oligonucleotide (5Ј-CAGAGGGACTTTCCGAGA-3Ј) was used as a probe and labeled by annealing of complementary primers followed by primer extension with the Klenow fragment of DNA polymerase I (Boehringer) in the presence of [␣- 
Statistical Analysis
Results of the experimental studies are reported as meanϮSEM, unless otherwise indicated. For paired comparisons, we used the paired t test, and differences between Ն3 variables were analyzed by ANOVA with the general linear model (SPSS version 8.0). A value of PϽ0.05 in the 2-tailed test was regarded as significant.
Results
Release of IL-6 and IL-1␤ and Endothelial Surface Expression of VCAM-1 After Coculture of Endothelial Cells and Monocytes
Coculture of purified monocytes with INF-␥-stimulated HUVECs for 24 hours resulted in a time-dependent release of IL-1␤ and IL-6 protein into the supernatant (Figure 1 ). After coculture with resting HUVECs, the release of IL-6 and IL-1␤ protein was significantly less, achieving only 20% or 34% of that obtained with INF-␥-stimulated HUVECs, respectively (Figures 1 and 2 ). Resting and INF-␥-activated HUVECs did not release detectable amounts of IL-6 or IL-1␤ when incubated alone. Likewise, monocytes incubated alone did not liberate detectable amounts of IL-6 protein, and their basal IL-1␤ release was just above the detection limit (4.65Ϯ0.85 pg/24 hours).
When resting or INF-␥-stimulated HUVECs and monocytes were placed in different compartments of transwell chambers, the release of IL-1␤ and IL-6 was reduced to the expression level obtained after interaction of monocytes with resting HUVECs (Figure 2) . Likewise, the increase in IL-6 release after binding of monocytes to INF-␥-stimulated HUVECs was completely abolished in the presence of IL-1RA (Figure 2) . IL-1RA, however, had no effect on the IL-1␤ release.
As with IL-6, coculture of monocytes with INF-␥-stimulated HUVECs induced an upregulation of endothelial VCAM-1 surface expression to 300Ϯ17% of the VCAM-1 expression on resting HUVECs incubated with monocytes (Pϭ0.02). Addition of IL-1RA significantly (Pϭ0.048) suppressed VCAM-1 surface expression after coculture of monocytes with INF-␥-stimulated HUVECs to 123Ϯ18% of the level achieved with resting HUVECs. A small, insignificant upregulation in VCAM-1 surface expression was found on resting HUVECs after coculture with monocytes.
Blocking mAbs against endothelial VCAM-1 or either the ␣ 4 -or ␤ 1 -subunit of monocyte VLA-4 abolished the increase in IL-6 and IL-1␤ protein release by coculture of monocytes and activated HUVECs, while blocking ICAM-1 mAbs had no such effect (Figure 3) . Similarly, blocking mAbs against E-selectin, P-selectin, or L-selectin given alone or in combination had no inhibitory effect on IL-1␤ and IL-6 release in our model (data not shown).
Expression of IL-1␤ mRNA and IL-6 mRNA and NF-B Activation After Coculture
We investigated the cellular source of cytokines by analyzing mRNA expression in each cell type separately. To facilitate 
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the recovery of large enough amounts of mRNA, we used mononuclear cells and ECV-304 cells in these experiments. The pattern of IL-1␤ and IL-6 protein expression after coculture of mononuclear cells with ECV-304 cells was similar to that after coculture of monocytes and HUVECs (Table) . 
Discussion
Our study sought to investigate cellular mechanisms that could link local vascular to systemic inflammatory responses in atherosclerosis. Because the atheromatous inflammatory reaction is characterized by recruitment of monocytes and T lymphocytes to the vessel wall, 2 
IL-1␤ and IL-6 Release by Coculture of Monocytes and Activated HUVECs
As a model for the activated endothelium in atherosclerosis, we used INF-␥-stimulated HUVECs. The phenotypic changes in our INF-␥-stimulated HUVECs were similar to those observed in the endothelium adjacent to subendothelial infiltrates of T lymphocytes and macrophages in atheromatous plaques. 18 T lymphocytes are known to secrete INF-␥ at the site of the atherosclerotic plaque. [1] [2] [3] This induces upregulation of the adhesion molecule ICAM-1 on the endothelial 
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surface 28, 29 and leads to endothelial expression of such leukotactic agents as IL-8 and MCP-1. 21 This effect is mediated by Janus kinase-dependent activation of signal transducer and activator of transcription (JAK-STAT) transcription factors. 30 INF-␥ itself, however, does not induce the NF-B-dependent pattern of immediate-early gene expression, as shown by others and by our study. 30, 31 Consistent with the fact that resting monocytes barely interact with resting endothelial cells, 32 we found substantial release of IL-1␤ and IL-6 only after coculture of monocytes with activated HUVECs. Likewise, prevention of adhesion by transwell chambers reduced cytokine production by adhesion of monocytes to activated HUVECs to the low level achieved by coculture with resting HUVECs. These findings demonstrate a central role of direct cellular interactions of monocytes with activated endothelium in the induction of IL-1␤ and IL-6 expression.
Analysis of mRNA for IL-1␤ and IL-6 in each cell type separately revealed monocytes as the major source for IL-1␤ and endothelial cells as the predominant source for IL-6. The release of IL-1␤ preceded the release of IL-6. Because it is known that IL-1␤ can induce expression of IL-6 and VCAM-1 in endothelial cells, 33, 34 we analyzed the role of IL-1␤ in the induction of the endothelial responses. IL-1RA almost completely inhibited endothelial VCAM-1 expression and IL-6 release induced by coculture of monocytes with activated HUVECs. These endothelial responses can thus be interpreted as an effect of monocyte-derived IL-1␤. IL-1RA, however, did not suppress IL-1␤ release, suggesting that there was no autocrine effect.
As suggested by recent studies, integrin signaling may account for adhesion-induced inflammatory responses. 21, 22, [35] [36] [37] We therefore investigated the role of integrinmediated cell interactions in our experimental setup. Our finding suggests a key role of binding of monocyte VLA-4 to endothelial VCAM-1. Blocking mAbs against either subunit of VLA-4 on monocytes or against its endothelial counterreceptor VCAM-1 abolished the adhesion-induced IL-1␤ release in monocytes as well as the resultant IL-6 release in endothelial cells. Conversely, blocking mAbs against ICAM-1 or selectins had no such effect. Thus, selectinsupported adhesion or ␤ 2 -integrin binding by ICAM-1 is not sufficient for the observed effects.
Our study shows that adhesion of mononuclear cells to endothelial cells induces activation and nuclear translocation of NF-B in both cell types. It is known that NF-B activation is a critical element in the regulation of both IL-1␤ and IL-6. 31, 38, 39 Our finding on NF-B activation is consistent with a recent study showing that cross-linking of VLA-4 induced NF-B activation in the monocytic cell lineage THP-1. 40 The early endothelial NF-B activation can be interpreted as an effect of ligation of endothelial surface receptors, such as VCAM-1, by adhering monocytes. Similarly, it has recently been shown that VCAM-1 mediates endothelial stimulation after adhesion of leukocytes, leading to a transient increase in endothelial cytosolic free calcium concentration. 41 
Comparison With Previous Studies
The results of our study are corroborated by previous studies in the monocytic cell line THP-1, which showed expression of IL-1␤ 42 and NF-B activation 40 after mAb ligation of VLA-4. Our study substantially extends the concept of ␤ 1 -integrin-regulated gene expression. It demonstrates the relevance of this pathway for the transcriptional regulation of NF-B-dependent genes in the physiological setting of cell adhesion. Among the various potential pathways of integrininduced cell activation, our study identifies VLA-4 signaling as the key mechanism for the induction of IL-1␤ after adhesion of monocytes to endothelial cells.
Our finding of differential expression of IL-1␤ and IL-6 mRNA in monocytes and endothelial cells after adhesioninduced NF-B activation is in accordance with other studies showing that cytokine-induced differential gene expression involves the synergistic interaction of a variable combinatorial set of transcription factors that assemble in response to specific stimuli in a unique complex. 43 
Limitations of the Study
Our study did not address the mechanisms of the weak stimulation of IL-1␤ and IL-6 release after coculture of monocytes with resting endothelial cells. A recent study showed platelet-derived growth factor expression as a consequence of monocyte adhesion to resting endothelial cells. 44 In our study, cytokine expression after coculture of monocytes with resting endothelial cells was essentially the same in transwell chambers. Hence, we suggest that as yet unidentified soluble factors were involved in this effect.
Previous studies revealed macrophages to be a source of IL-6 in atheroma and in the border zone of reperfused myocardium. 45, 46 In our experimental setting, we were unable to demonstrate substantial IL-6 mRNA expression in monocytes, whereas a strong IL-6 mRNA signal was found in endothelial cells. We cannot fully exclude minor monocyte contamination of the endothelial fraction. Nevertheless, this could not account for the IL-6 mRNA signal in this fraction, because mRNA of the monocyte-specific ␤ 2 -integrin chain was not detectable. Our inability to detect substantial IL-6 mRNA in the monocyte fraction may be explained by the time frame of our study. We focused on early inflammatory responses after adhesion of monocytes to preactivated endothelium but did not address the late events after differentiation of monocytes to IL-6 -expressing macrophages.
Potential Clinical and Therapeutic Implications
The cellular interactions we describe may play a major role in the regulation of both local and systemic inflammatory responses in atherosclerosis ( Figure 6 ). When monocytes adhere to the INF-␥-activated endothelium of atherosclerotic lesions, binding of monocyte VLA-4 to endothelial VCAM-1 may induce NF-B activation with expression and release of IL-1␤ by monocytes. This, in turn, could enhance local inflammatory responses by promoting further monocyte attachment through increased endothelial surface expression of VCAM-1 and simultaneously induce systemic inflammatory responses by stimulating the release of IL-6 from the endothelium. Binding of monocytes to activated endothelial cells by interaction of VLA-4 and VCAM-1 may thus represent one of the earliest events in the inflammatory cascade of atherosclerosis.
The functional relevance of VLA-4/VCAM-1 interactions is underscored by animal studies showing that blockade of VLA-4 attenuates monocyte recruitment to atherosclerotic plaques. 47 Our present study demonstrates that the interaction of VLA-4 with VCAM-1 induces IL-1␤-dependent local inflammatory responses promoting atherogenesis as well as IL-6 -dependent systemic inflammatory responses. Inhibition of this interaction may constitute a novel therapeutic strategy for modification of inflammatory cardiovascular risk factors, such as fibrinogen upregulation.
